Articles

UofT Libraries is getting a new library services platform in January 2021.
Learn more about the change.

Search Articles

Advanced search
Help

Catalogue

Articles

Databases

X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (321716) 321716
Book Chapter (1732) 1732
Magazine Article (1184) 1184
Conference Proceeding (640) 640
Dissertation (437) 437
Publication (320) 320
Book / eBook (160) 160
Web Resource (59) 59
Poster (53) 53
Reference (36) 36
Government Document (23) 23
Book Review (12) 12
Paper (12) 12
Journal / eJournal (8) 8
Newsletter (7) 7
Streaming Video (4) 4
Data Set (1) 1
Trade Publication Article (1) 1
Video Recording (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (291100) 291100
recurrence (200310) 200310
female (193148) 193148
science & technology (182158) 182158
life sciences & biomedicine (176836) 176836
male (175497) 175497
middle aged (144178) 144178
adult (131529) 131529
aged (107601) 107601
treatment outcome (58914) 58914
follow-up studies (55991) 55991
retrospective studies (49280) 49280
surgery (48585) 48585
adolescent (46783) 46783
abridged index medicus (46384) 46384
prognosis (44440) 44440
oncology (44372) 44372
neoplasm recurrence, local (39974) 39974
aged, 80 and over (37050) 37050
risk factors (33937) 33937
child (33866) 33866
time factors (31050) 31050
neoplasm recurrence, local - pathology (24956) 24956
neoplasm staging (23635) 23635
child, preschool (20604) 20604
survival rate (20568) 20568
prospective studies (19609) 19609
combined modality therapy (19401) 19401
cancer (19071) 19071
care and treatment (18773) 18773
young adult (17924) 17924
disease-free survival (17694) 17694
medicine & public health (17194) 17194
cardiovascular system & cardiology (15901) 15901
analysis (15828) 15828
neoplasm recurrence, local - surgery (14605) 14605
neurosciences & neurology (14276) 14276
survival analysis (13678) 13678
infant (13511) 13511
antineoplastic combined chemotherapy protocols - therapeutic use (13429) 13429
relapse (12952) 12952
gastroenterology & hepatology (12716) 12716
clinical neurology (12377) 12377
research (12110) 12110
cardiac & cardiovascular systems (12025) 12025
reoperation (11627) 11627
animals (11597) 11597
general & internal medicine (11555) 11555
health aspects (11471) 11471
tomography, x-ray computed (11256) 11256
lymphatic metastasis (11101) 11101
hematology (10898) 10898
medicine, general & internal (10585) 10585
diagnosis, differential (10501) 10501
chemotherapy (10319) 10319
neoplasm recurrence, local - diagnosis (10175) 10175
neoplasm recurrence, local - drug therapy (9982) 9982
neoplasm recurrence, local - mortality (9884) 9884
magnetic resonance imaging (9594) 9594
patients (9427) 9427
urology & nephrology (9353) 9353
diseases (9328) 9328
radiology, nuclear medicine & medical imaging (9188) 9188
neoplasm metastasis (9157) 9157
age factors (8977) 8977
radiotherapy (8796) 8796
disease progression (8598) 8598
chronic disease (8544) 8544
multivariate analysis (8536) 8536
pediatrics (8489) 8489
neoplasm recurrence, local - epidemiology (8446) 8446
postoperative complications (8381) 8381
cohort studies (8371) 8371
tumors (8361) 8361
kaplan-meier estimate (8356) 8356
breast cancer (8287) 8287
breast neoplasms - pathology (8275) 8275
risk assessment (8272) 8272
incidence (8245) 8245
metastasis (8135) 8135
predictive value of tests (7806) 7806
neoplasm recurrence, local - prevention & control (7768) 7768
proportional hazards models (7552) 7552
obstetrics & gynecology (7488) 7488
acute disease (7068) 7068
antineoplastic agents - therapeutic use (7021) 7021
radiography (7013) 7013
immunohistochemistry (6963) 6963
biopsy (6817) 6817
survival (6807) 6807
neoplasm invasiveness (6649) 6649
remission induction (6515) 6515
neoplasm recurrence, local - therapy (6471) 6471
dentistry (6453) 6453
diagnosis (6442) 6442
transplantation (6378) 6378
psychiatry (6354) 6354
pathology (6311) 6311
medical research (6164) 6164
research article (6082) 6082
more...
Library Location Library Location
Library Location Library Location
X
Sort by Item Count (A-Z)
Filter by Count
Gerstein Science - Stacks (61) 61
Online Resources - Online (28) 28
Mathematical Sciences - Stacks (19) 19
Collection Dvlpm't (Acquisitions) - Vendor file (15) 15
Robarts - Stacks (14) 14
UofT at Mississauga - Stacks (12) 12
St. Michael's College (John M. Kelly) - 3rd Floor (7) 7
UofT at Scarborough - Stacks (6) 6
Collection Dvlpm't (Acquisitions) - Closed Orders (5) 5
Stacks (5) 5
Engineering & Comp. Sci. - Stacks (4) 4
Victoria University E.J. Pratt - Stacks (4) 4
Trinity College (John W Graham) - Stacks (3) 3
Physics - Stacks (2) 2
Pontifical Inst. Mediaeval Studies - Library use only (2) 2
Sunnybrook Health Sciences Centre - Sunnybrook Stacks (2) 2
Victoria University Emmanuel College - Stacks (2) 2
Knox College (Caven) - Stacks (1) 1
OISE - Audio Visual (1) 1
OISE - Stacks (1) 1
Robarts - Course Reserves (1) 1
Scarborough Hospital - Online (1) 1
Sunnybrook Health Sciences Centre - Online (1) 1
Sunnybrook Health Sciences Centre - Sunnybrook Patient Education (1) 1
Trinity College (John W Graham) - Storage (1) 1
UTL at Downsview - May be requested (1) 1
UofT at Mississauga - 1st Floor (1) 1
UofT at Mississauga - Missing (1) 1
Victoria University CRRS - Library use only (1) 1
Victoria University Emmanuel College - Sunnybrook Stacks (1) 1
West Park Healthcare Centre - Stacks (1) 1
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (282214) 282214
German (13272) 13272
French (10193) 10193
Japanese (7463) 7463
Russian (6939) 6939
Chinese (3912) 3912
Spanish (2716) 2716
Italian (2713) 2713
Polish (1945) 1945
Portuguese (1480) 1480
Korean (806) 806
Czech (664) 664
Danish (625) 625
Dutch (443) 443
Hungarian (425) 425
Bulgarian (328) 328
Swedish (299) 299
Norwegian (285) 285
Hebrew (229) 229
Romanian (191) 191
Serbian (159) 159
Ukrainian (148) 148
Croatian (139) 139
Finnish (131) 131
Slovak (131) 131
Turkish (126) 126
Lithuanian (41) 41
Persian (38) 38
Greek (20) 20
Icelandic (15) 15
Bosnian (13) 13
Afrikaans (7) 7
Slovenian (6) 6
Arabic (4) 4
Latvian (3) 3
Thai (3) 3
Azerbaijani (2) 2
Welsh (2) 2
Belarusian (1) 1
Catalan (1) 1
Estonian (1) 1
Indonesian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


1. After breast cancer
: answers to the questions you're afraid to ask
by Mayer, Musa
2003, 1st ed., Patient-centered guides, ISBN 9780596507831, xv, 196
Breast | Relapse | Cancer
Book
Details down arrow
2. Full Text Imatinib for Melanomas Harboring Mutationally Activated or Amplified KIT Arising on Mucosal, Acral, and Chronically Sun-Damaged Skin
by Hodi, F. Stephen and Corless, Christopher L and Giobbie-Hurder, Anita and Fletcher, Jonathan A and Zhu, Meijun and Marino-Enriquez, Adrian and Friedlander, Philip and Gonzalez, Rene and Weber, Jeffrey S and Gajewski, Thomas F and O'Day, Steven J and Kim, Kevin B and Lawrence, Donald and Flaherty, Keith T and Luke, Jason J and Collichio, Frances A and Ernstoff, Marc S and Heinrich, Michael C and Beadling, Carol and Zukotynski, Katherine A and Yap, Jeffrey T and Van den Abbeele, Annick D and Demetri, George D and Fisher, David E
Journal of clinical oncology, ISSN 1527-7755, 09/2013, Volume 31, Issue 26, pp. 3182 - 3190
Purpose Amplifications and mutations in the KIT proto-oncogene in subsets of melanomas provide therapeutic opportunities. Patients and Methods We conducted a... 
Life Sciences & Biomedicine | Oncology | Science & Technology | Prognosis | Skin Neoplasms - drug therapy | Humans | Middle Aged | Neoplasm Recurrence, Local - drug therapy | Male | Antineoplastic Agents - therapeutic use | Neoplasm Recurrence, Local - mortality | Neoplasm Recurrence, Local - pathology | Benzamides - therapeutic use | Melanoma - genetics | Skin Neoplasms - mortality | Aged, 80 and over | Adult | Female | Proto-Oncogene Proteins c-kit - genetics | Mucous Membrane - drug effects | Membrane Proteins - genetics | Survival Rate | Piperazines - therapeutic use | Melanoma - pathology | Mutation - genetics | Imatinib Mesylate | Mucous Membrane - pathology | Gene Amplification | GTP Phosphohydrolases - genetics | Pyrimidines - therapeutic use | Melanoma - drug therapy | Skin Neoplasms - genetics | Skin Neoplasms - secondary | Sunlight | Neoplasm Recurrence, Local - genetics | Aged | Biomarkers, Tumor - genetics | Chronic Disease | Melanoma - mortality | Index Medicus | Timg2 | Esp | Mela5 | Timg4 | Fra | Timg3 | Mela7 | To21 | ORIGINAL REPORTS
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
3. Full Text Nomograms for Predicting Local Recurrence, Distant Metastases, and Overall Survival for Patients With Locally Advanced Rectal Cancer on the Basis of European Randomized Clinical Trials
by Valentini, Vincenzo and van Stiphout, Ruud G.P.M and Lammering, Guido and Gambacorta, Maria Antonietta and Barba, Maria Cristina and Bebenek, Marek and Bonnetain, Franck and Bosset, Jean-Francois and Bujko, Krzysztof and Cionini, Luca and Gerard, Jean-Pierre and Rödel, Claus and Sainato, Aldo and Sauer, Rolf and Minsky, Bruce D and Collette, Laurence and Lambin, Philippe
Journal of clinical oncology, ISSN 1527-7755, 08/2011, Volume 29, Issue 23, pp. 3163 - 3172
Purpose The purpose of this study was to develop accurate models and nomograms to predict local recurrence, distant metastases, and survival for patients with... 
Life Sciences & Biomedicine | Oncology | Science & Technology | Models, Theoretical | Age Factors | Europe | Humans | Middle Aged | Kaplan-Meier Estimate | Male | Neoplasm Recurrence, Local - mortality | Rectal Neoplasms - mortality | Randomized Controlled Trials as Topic | Neoplasm Recurrence, Local - pathology | Neoplasm Metastasis | Sex Factors | Adult | Female | Aged | Rectal Neoplasms - pathology | Index Medicus | Neoplasm Recurrence, Local | Life Sciences | Rectal Neoplasms | Cancer
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
4. Full Text Evaluation of PIK3CA Mutation As a Predictor of Benefit From Nonsteroidal Anti-Inflammatory Drug Therapy in Colorectal Cancer
by Domingo, Enric and Church, David N and Sieber, Oliver and Ramamoorthy, Rajarajan and Yanagisawa, Yoko and Johnstone, Elaine and Davidson, Brian and Kerr, David J and Tomlinson, Ian P.M and Midgley, Rachel
Journal of clinical oncology, ISSN 1527-7755, 12/2013, Volume 31, Issue 34, pp. 4297 - 4305
Purpose Aspirin and other nonsteroidal anti-inflammatory drugs (NSAIDs) protect against colorectal cancer (CRC) and are associated with reduced disease... 
Life Sciences & Biomedicine | Oncology | Science & Technology | Colorectal Neoplasms - surgery | Multivariate Analysis | Sulfones - therapeutic use | Colorectal Neoplasms - genetics | Humans | Middle Aged | Male | Colectomy | Neoplasm Recurrence, Local - enzymology | Patient Selection | Neoplasm Recurrence, Local - pathology | Time Factors | DNA Mutational Analysis | Colorectal Neoplasms - drug therapy | Aged, 80 and over | Adult | Female | Aspirin - therapeutic use | Chemotherapy, Adjuvant | Colorectal Neoplasms - mortality | Colorectal Neoplasms - enzymology | Genetic Predisposition to Disease | Neoplasm Recurrence, Local - prevention & control | Risk Assessment | Risk Factors | Kaplan-Meier Estimate | Proportional Hazards Models | Treatment Outcome | Cyclooxygenase 2 - analysis | Lactones - therapeutic use | Phosphatidylinositol 3-Kinases - genetics | Disease-Free Survival | Phenotype | Class I Phosphatidylinositol 3-Kinases | Anti-Inflammatory Agents, Non-Steroidal - therapeutic use | Neoplasm Recurrence, Local - genetics | Aged | Mutation | Colorectal Neoplasms - pathology | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
5. Full Text Results From a Prospective, Open-Label, Phase II Trial of Bendamustine in Refractory or Relapsed T-Cell Lymphomas: The BENTLY Trial
by Gandhi Damaj and Rémy Gressin and Krimo Bouabdallah and Guillaume Cartron and Bachra Choufi and Emmanuel Gyan and Anne Banos and Arnaud Jaccard and Sophie Park and Olivier Tournilhac and Jean-Marc Schiano-de Collela and Laurent Voillat and Bertrand Joly and Steven Le Gouill and Alain Saad and Pascale Cony-Makhoul and Jean-Pierre Vilque and Laurence Sanhes and Aline Schmidt-Tanguy and Michael Bubenheim and Roch Houot and Momar Diouf and Jean-Pierre Marolleau and Marie-Christine Béné and Antoine Martin and Thierry Lamy
Journal of Clinical Oncology, ISSN 0732-183X, 01/2013, Volume 31, Issue 1, pp. 104 - 110
Purpose To determine the efficacy and safety of bendamustine as a single agent in refractory or relapsed T-cell lymphomas. Patients and Methods Patients with... 
Life Sciences & Biomedicine | Oncology | Science & Technology | Prognosis | Prospective Studies | Follow-Up Studies | Humans | Middle Aged | Salvage Therapy | Neoplasm Recurrence, Local - drug therapy | Male | Lymphoma, T-Cell, Cutaneous - drug therapy | Neoplasm Recurrence, Local - mortality | Neoplasm Recurrence, Local - pathology | Nitrogen Mustard Compounds - therapeutic use | Aged, 80 and over | Adult | Female | Lymphoma, T-Cell, Peripheral - drug therapy | Lymphoma, T-Cell, Cutaneous - mortality | Survival Rate | Remission Induction | Antineoplastic Agents, Alkylating - therapeutic use | Lymphoma, T-Cell, Cutaneous - pathology | Bendamustine Hydrochloride | Lymphoma, T-Cell, Peripheral - pathology | Aged | Neoplasm Staging | Lymphoma, T-Cell, Peripheral - mortality | Drug Resistance, Neoplasm - drug effects | Index Medicus | Lymphoma, T-Cell, Cutaneous | Biochemistry, Molecular Biology | Neoplasm Recurrence, Local | Lymphoma, T-Cell, Peripheral | Drug Resistance, Neoplasm | Nitrogen Mustard Compounds | Cellular Biology | Life Sciences | Antineoplastic Agents, Alkylating
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
6. Full Text Discordance between oncotype DX recurrence score and RSPC for predicting residual risk of recurrence in ER-positive breast cancer
by Dodson, Andrew and Okonji, David and Assersohn, Laura and Rigg, Anne and Sheri, Amna and Turner, Nick and Smith, Ian and Parton, Marina and Dowsett, Mitch
Breast cancer research and treatment, ISSN 1573-7217, 11/2017, Volume 168, Issue 1, pp. 249 - 258
Oncotype DX, a gene expression assay widely employed to aid decision making on adjuvant chemotherapy use in patients with primary oestrogen receptor-positive... 
Recurrence risk | Medicine & Public Health | RSPC, prognosis | Oncology | Breast cancer | Oncotype DX | Recurrence score | Life Sciences & Biomedicine | Science & Technology | Breast Neoplasms, Male - genetics | Predictive Value of Tests | Risk Assessment - methods | Receptors, Estrogen - metabolism | Prognosis | Breast - surgery | Humans | Middle Aged | Male | Genetic Testing - methods | Incidence | Patient Selection | Breast Neoplasms - therapy | Antineoplastic Agents, Hormonal - therapeutic use | Mastectomy | Adult | Female | Breast Neoplasms, Male - epidemiology | Breast - pathology | Breast Neoplasms - epidemiology | Neoplasm Recurrence, Local - prevention & control | Gene Expression Profiling - methods | Neoplasm Recurrence, Local - diagnosis | Breast Neoplasms - genetics | Breast Neoplasms, Male - therapy | Breast Neoplasms - pathology | Chemotherapy, Adjuvant - methods | Neoplasm Recurrence, Local - genetics | Aged | Neoplasm Recurrence, Local - epidemiology | Breast Neoplasms, Male - pathology | United Kingdom - epidemiology | Medical research | Relapse | Adjuvant treatment | Estrogen | Societies | Gene expression | Diseases | Medicine, Experimental | Diagnosis | Associations, institutions, etc | Cancer | Index Medicus | Brief Report
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
7. Full Text Patterns, Timing, and Predictors of Recurrence Following Pancreatectomy for Pancreatic Ductal Adenocarcinoma
by Groot, Vincent P and Rezaee, Neda and Wu, Wenchuan and Cameron, John L and Fishman, Elliot K and Hruban, Ralph H and Weiss, Matthew J and Zheng, Lei and Wolfgang, Christopher L and He, Jin
Annals of surgery, ISSN 0003-4932, 05/2018, Volume 267, Issue 5, pp. 936 - 945
OBJECTIVE:To describe accurately the pattern, timing, and predictors of disease recurrence after a potentially curative resection for pancreatic ductal... 
predictors for recurrence | recurrence location | recurrence-free survival | cancer recurrence | pancreatectomy | pancreatic ductal adenocarcinoma | Life Sciences & Biomedicine | Surgery | Science & Technology | Maryland - epidemiology | Prognosis | Survival Rate - trends | Follow-Up Studies | Pancreatic Neoplasms - diagnosis | Humans | Pancreatic Neoplasms - surgery | Pancreatectomy | Postoperative Period | Male | Carcinoma, Pancreatic Ductal - surgery | Incidence | Time Factors | Carcinoma, Pancreatic Ductal - diagnosis | Female | Aged | Neoplasm Recurrence, Local - epidemiology | Retrospective Studies
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
8. Full Text Randomized Phase II Trial of Onartuzumab in Combination With Erlotinib in Patients With Advanced Non–Small-Cell Lung Cancer
by Spigel, David R and Ervin, Thomas J and Ramlau, Rodryg A and Daniel, Davey B and Goldschmidt, Jerome H and Blumenschein, George R and Krzakowski, Maciej J and Robinet, Gilles and Godbert, Benoit and Barlesi, Fabrice and Govindan, Ramaswamy and Patel, Taral and Orlov, Sergey V and Wertheim, Michael S and Yu, Wei and Zha, Jiping and Yauch, Robert L and Patel, Premal H and Phan, See-Chun and Peterson, Amy C
Journal of clinical oncology, ISSN 1527-7755, 11/2013, Volume 31, Issue 32, pp. 4105 - 4114
Increased hepatocyte growth factor/MET signaling is associated with poor prognosis and acquired resistance to epidermal growth factor receptor (EGFR) -targeted... 
Erlotinib Hydrochloride | Immunohistochemistry | Lung Neoplasms - drug therapy | Proto-Oncogene Proteins c-met - biosynthesis | Lung Neoplasms - mortality | Humans | Lung Neoplasms - metabolism | Middle Aged | Antibodies, Monoclonal - adverse effects | Neoplasm Recurrence, Local - drug therapy | Male | Neoplasm Recurrence, Local - mortality | Aged, 80 and over | Adult | Female | Quinazolines - administration & dosage | Double-Blind Method | Neoplasm Recurrence, Local - metabolism | Carcinoma, Non-Small-Cell Lung - metabolism | Kaplan-Meier Estimate | Proportional Hazards Models | Treatment Outcome | Carcinoma, Non-Small-Cell Lung - mortality | Cross-Over Studies | Disease-Free Survival | Antibodies, Monoclonal - administration & dosage | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Quinazolines - adverse effects | Aged | Carcinoma, Non-Small-Cell Lung - drug therapy | Index Medicus | Thor9 | Thor12 | ORIGINAL REPORTS | To2 | To20 | Thor6
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
9. Full Text Avelumab, an anti-PD-L1 antibody, in patients with locally advanced or metastatic breast cancer: a phase 1b JAVELIN Solid Tumor study
by Dirix, Luc Y and Takacs, Istvan and Jerusalem, Guy and Nikolinakos, Petros and Arkenau, Hendrik-Tobias and Forero-Torres, Andres and Boccia, Ralph and Lippman, Marc E and Somer, Robert and Smakal, Martin and Emens, Leisha A and Hrinczenko, Borys and Edenfield, William and Gurtler, Jayne and von Heydebreck, Anja and Grote, Hans Juergen and Chin, Kevin and Hamilton, Erika P
Breast cancer research and treatment, ISSN 1573-7217, 10/2017, Volume 167, Issue 3, pp. 671 - 686
Agents targeting programmed death receptor 1 (PD-1) or its ligand (PD-L1) have shown antitumor activity in the treatment of metastatic breast cancer (MBC). The... 
Medicine & Public Health | Avelumab | PD-L1 | Oncology | Metastatic breast cancer | Second-line | Triple-negative breast cancer | Life Sciences & Biomedicine | Science & Technology | Humans | Middle Aged | Antibodies, Monoclonal - adverse effects | Neoplasm Recurrence, Local - drug therapy | Triple Negative Breast Neoplasms - drug therapy | B7-H1 Antigen - genetics | B7-H1 Antigen - immunology | Neoplasm Recurrence, Local - immunology | Neoplasm Recurrence, Local - pathology | Disease-Free Survival | Antibodies, Anti-Idiotypic - administration & dosage | Neoplasm Metastasis | B7-H1 Antigen - antagonists & inhibitors | Triple Negative Breast Neoplasms - genetics | Antibodies, Monoclonal - administration & dosage | Triple Negative Breast Neoplasms - pathology | Adult | Female | Aged | Gene Expression Regulation, Neoplastic - drug effects | Immunohistochemistry | Viral antibodies | Care and treatment | Oncology, Experimental | Antibodies | Breast cancer | Metastasis | Research | Cancer | Index Medicus | Clinical Trial
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
10. Full Text Tumor-Specific Methylation in Saliva: A Promising Biomarker for Early Detection of Head and Neck Cancer Recurrence
by Righini, C. A and de Fraipont, F and Timsit, J.-F and Faure, C and Brambilla, E and Reyt, E and Favrot, M.-C
Clinical cancer research, ISSN 1557-3265, 02/2007, Volume 13, Issue 4, pp. 1179 - 1185
Purpose: Our goal was to define tumor and saliva gene methylation profile of head and neck squamous cell carcinoma and to evaluate its prognostic significance... 
saliva | recurrence | detection | tumor suppressor gene methylation | HNSCC | Life Sciences & Biomedicine | Oncology | Science & Technology | Prognosis | Prospective Studies | Neoplasm Recurrence, Local - metabolism | Carcinoma, Squamous Cell - genetics | Carcinoma, Squamous Cell - metabolism | Humans | Middle Aged | Male | Head and Neck Neoplasms - metabolism | DNA Methylation | Saliva - metabolism | Biomarkers, Tumor - metabolism | Adult | Female | Head and Neck Neoplasms - genetics | Neoplasm Recurrence, Local - genetics | Aged | Biomarkers, Tumor - genetics | Index Medicus | Tumor Markers, Biological | Neoplasm Recurrence, Local | Head and Neck Neoplasms | Carcinoma, Squamous Cell | Life Sciences | Saliva | Cancer
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
11. Full Text A Randomized Trial Comparing Postoperative Adjuvant Chemotherapy with Cisplatin and 5-Fluorouracil Versus Preoperative Chemotherapy for Localized Advanced Squamous Cell Carcinoma of the Thoracic Esophagus (JCOG9907)
by Ando, Nobutoshi and Kato, Hoichi and Igaki, Hiroyasu and Shinoda, Masayuki and Ozawa, Soji and Shimizu, Hideaki and Nakamura, Tsutomu and Yabusaki, Hiroshi and Aoyama, Norio and Kurita, Akira and Ikeda, Kenichiro and Kanda, Tatsuo and Tsujinaka, Toshimasa and Nakamura, Kenichi and Fukuda, Haruhiko
Annals of surgical oncology, ISSN 1534-4681, 08/2011, Volume 19, Issue 1, pp. 68 - 74
Patients with esophageal carcinoma receiving postoperative chemotherapy showed superior disease-free survival than those receiving surgery alone in a Japan... 
Oncology | Medicine & Public Health | Surgical Oncology | Surgery | Life Sciences & Biomedicine | Science & Technology | Follow-Up Studies | Humans | Middle Aged | Neoplasm Recurrence, Local - drug therapy | Carcinoma, Squamous Cell - surgery | Male | Neoplasm Recurrence, Local - mortality | Neoplasm Recurrence, Local - surgery | Cisplatin - administration & dosage | Carcinoma, Squamous Cell - mortality | Fluorouracil - administration & dosage | Esophageal Neoplasms - surgery | Esophageal Neoplasms - mortality | Adult | Female | Chemotherapy, Adjuvant | Postoperative Period | Esophagectomy | Survival Rate | Treatment Outcome | Combined Modality Therapy | Carcinoma, Squamous Cell - drug therapy | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Aged | Neoplasm Staging | Esophageal Neoplasms - drug therapy | Preoperative Period | Medical colleges | Squamous cell carcinoma | Analysis | Adjuvant treatment | Censorship | Esophageal cancer | Cisplatin | Fluorouracil | Cancer | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights